GlassScriptPhysician profile
Jeffrey M Marks
NPI 1881614501
$42,170.40
in general payments reported to CMS, 2019-2025
32 companies · $969 in 2025
The $969 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,290 · 2020: $24K · 2021: $9,167 · 2022: $926 · 2023: $3,170 · 2024: $766 · 2025: $969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Food and Beverage: $2,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Food and Beverage | $2,404.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $37,715.80 | 2019-2025 | Spyglass Discover, General - Therapies, Exalt Model D |
| US Endoscopy | $750.00 | 2021-2022 | |
| Davol INC. | $432.80 | 2019 | |
| Lumendi LLC | $400.00 | 2021 | |
| Aroa Biosurgery Incorporated | $388.31 | 2022-2025 | |
| Tela Bio, INC. | $307.35 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| W. L. Gore & Associates, INC. | $273.45 | 2023-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Integra Lifesciences Corporation | $164.53 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Pfizer INC. | $144.70 | 2022-2025 | |
| Ethicon US, LLC | $139.39 | 2023-2025 | Stratafix, Surgicel Nu-Knit, Harmonic |
| Dilon Technologies, INC. | $131.86 | 2023 | Hemoblast Bellows |
| Baxter Healthcare | $125.53 | 2025 | Floseal |
| Medical Device Business Services, INC. | $110.32 | 2021 | |
| Medtronic, INC. | $105.99 | 2024 | Ligasure |
| Kci USA, INC. | $100.16 | 2023 | V.A.C. Veraflo, Abthera |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steris Corporation | $96.03 | 2025 | |
| Asensus Surgical, INC. | $91.01 | 2019 | |
| Madrigal Pharmaceuticals | $89.91 | 2025 | Rezdiffra |
| Astellas Pharma US INC | $89.24 | 2021-2023 | Myrbetriq |
| Intuitive Surgical, INC. | $77.04 | 2024 | |
| Abbvie INC. | $71.89 | 2019-2024 | |
| Urovant Sciences INC | $58.32 | 2022 | |
| Teleflex LLC | $54.32 | 2019 | |
| Antares Pharma, INC. | $52.94 | 2022 | |
| Amgen INC. | $37.84 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $29.85 | 2023 | Gemtesa |
| Clarus Therapeutics INC. | $28.89 | 2021 | |
| Becton, Dickinson and Company | $28.24 | 2023 | Phasix Mesh |
| Tolmar Pharmaceuticals, INC. | $21.33 | 2022 | |
| Innovation Technologies INC | $21.31 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.15 | 2019 | |
| Axonics, INC. | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.